Polifarma S.p.A.
19Patents
0Active
19Granted
31Portfolio score
Filing activity: Oct 7, 1983 → May 9, 2000
Most-cited patents
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US5962459A | Therapeutic active agent for treatment of neuron degenerative diseases | Human Necessities | 22 | Expired |
| US4960759A | Pharmacological use of uridine in the treatment of nervous disorders | Chemistry; Metallurgy | 18 | Expired |
| US4551471A | Use of 3-indolepyruvic acid for increasing serotonin | Emerging Cross-Sectional Technologies | 17 | Expired |
| US4619916A | Tripeptide compounds containing pyroglutamic acid and tryptophan, process for their production and therapeutic applications | Human Necessities | 15 | Expired |
| US5210215A | Tryptophane and 3-indolepyruvic acid, methods of production therefor | Chemistry; Metallurgy | 15 | Expired |
| US6057297A | Inhibitor compounds of zinc-dependent metalloproteinases associated with pathological conditions, and therapeutic use thereof | Human Necessities | 14 | Expired |
| US4808728A | Production of indolepyruvic acid and the 5-hydroxy derivative thereof | Chemistry; Metallurgy | 10 | Expired |
| US4748155A | Pharmacologically active tripeptides and process for their synthesis | Chemistry; Metallurgy | 8 | Expired |
| US5143903A | Method of treatment with tripeptide pharmaceutical compositions as immunomodulators | Human Necessities | 7 | Expired |
| US5190948A | Use of uridine in the pharmacological treatment of the peripheral complications of diabetes | Human Necessities | 6 | Expired |
| US6339160B1 | Metalloproteinase inhibitors, their therapeutic use and process for the production of the starting compound in the synthesis thereof | Human Necessities | 3 | Expired |
| US5447951A | Method for reducing the level of glucocorticoids in the blood and preventing cerebral disturbances | Human Necessities | 2 | Expired |
| US5051404A | Tripeptide compounds having hypotensive activity | Emerging Cross-Sectional Technologies | 2 | Expired |
| US5504071A | Compounds with a sequence of three radicals, the central one being .alpha.- a | Emerging Cross-Sectional Technologies | 2 | Expired |
| US5091172A | Cosmetic use of 3-indolepyruvic acid | Human Necessities | 1 | Expired |
| US4713368A | Peptido-mimetic substances with hypotensive action | Chemistry; Metallurgy | 1 | Expired |
| US5075329A | Use of 3-indolepyruvic acid as a pharmaceutical agent for the inhibition of peripheral degenerative pathologies | Human Necessities | 1 | Expired |
| US5736518A | Peptide compounds of (L) amino acids and ring molecules, and therapeutical applications thereof | Emerging Cross-Sectional Technologies | 0 | Expired |
| US5846755A | Method for determining the therapeutic activity of metalloproteinase inhibitor compounds | Physics | 0 | Expired |
Source: USPTO / EPO open patent data. Counts and citation impact are objective bibliographic measures.